Crossref
Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma
AME Clinical Trials Review · 2026-04 · 4 · 16-16
DOI: 10.21037/actr-25-92 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-04. Verfasst von Carolyn Moloney-Lineen und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Moloney-Lineen, C., & Mahalingam, D. (2026). Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma. AME Clinical Trials Review, 4, 16-16. https://doi.org/10.21037/actr-25-92
Vancouver
Moloney-Lineen C, Mahalingam D. Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma. AME Clinical Trials Review. 2026;4:16-16. doi:10.21037/actr-25-92
BibTeX
@article{MoloneyLineen2026,
author = {Moloney-Lineen, Carolyn and Mahalingam, Devalingam},
title = {Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma},
journal = {AME Clinical Trials Review},
year = {2026},
volume = {4},
pages = {16--16},
doi = {10.21037/actr-25-92}
}
EUVIMED